Journals / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 3

Barriers to Women's Pap Smear Testing and Related Risk Factors in Turkey

Pages
203–209
Publication Date
2020-09-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To improve access to health services, mobile health services need to be developed, and in hospitals, routine Pap smear test health educations should be conducted and guidance should be provided.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to identify the barriers to women's Pap smear testing and related risk factors.
📊
Key Findings & Data:Methods: In this descriptive and cross‐sectional study, 294 women were included by stratified random sampling.
💡
Conclusion & Impact:To improve access to health services, mobile health services need to be developed, and in hospitals, routine Pap smear test health educations should be conducted and guidance should be provided.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:cervical cancer · screening · barriers

Abstract

Objective: This study aimed to identify the barriers to women's Pap smear testing and related risk factors. Methods: In this descriptive and cross‐sectional study, 294 women were included by stratified random sampling. The General Information Questionnaire, The Self-Efficacy Scale, The Health Belief Model Scale for Cervical Cancer, and the Pap Smear Test were used. Results: About half of the women (47.6%) had a Pap smear test in their lifetime.Residing in a village/non-provincial district (OR = 0.412), not having a Pap smear test because family members/friends did not have one (OR = 7.752), having high Barriers subscale scores (OR = 1.053), and having lower self-efficacy levels (OR = 0.951) were found to be risk factors for having a Pap smear test.In addition, not knowing the symptoms of cervical cancer, believing that the cervical cancer is a non-treatable condition, expecting to experience vaginal infection,not being able to get permission from her husband, and considering the test as embarrassing were found among the barriers (p < 0.005). Conclusions: A well designed health education program focusing on cervical cancer and the benefits of screening would increase awareness, especially among women with a high educational attainment status.Public health nurses should provide health educations considering the local cultural environment. To improve access to health services, mobile health services need to be developed, and in hospitals, routine Pap smear test health educations should be conducted and guidance should be provided.

🔖

Cite This Article

ÇANKAYA, S., YÜKSEL, G. (2020). Barriers to Women's Pap Smear Testing and Related Risk Factors in Turkey. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 3, 203–209. https://ajindex.com/articles/481436

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. REFERENCES1. McGuire S. World cancer report 2014.
  2. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015. https://doi.org/10.3945/an.116.0122112.
  3. Stewart BWKP, Wild CP. World cancer report 2014. Public Health. Acessed April 21, 2019 from http://publichealthwell.ie/search-results/world-cancer-report-2014?source=relatedblock&content=resource&member=572160&catalogue=none&collection=Conditions,Chronic%20Conditions,Cancer&tokens_complete=true3. Turkish Public Health Institution (TPHI). Cancer Statistics Turkey, 2018. Acessed March 24, 2019 from https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf4. Turkish Statistical Institute (TSI). Pap smear making status, 2012. Acessed May 15, 2019 from http://www.tuik.gov.tr/IcerikGetir.do?istab_id=223. (Turkish)5. T. C. Ministry of Health Statistics. Annual Part 3: Morbidity, 2016. Acessed May 15, 2019 from https://dosyasb.saglik.gov.tr/Eklenti/13183,sy2016turkcepdf.pdf6.
  4. Kög İ, Turan T, Karabük E, et al. Cervical and breast cancer screening programme results of Etlik KETEM Group. TAF Preventive Medicine Bulletin. 2012;11(2):145–152. (Original work published in Turkish). DOI: 10.5455/pmb.20110812120702.7. Solt A, Dutucu N, Gunaydin S, Citil ET, Arik E. Evaluation of the PAP Smear Test Status of Women and Affecting Factors. International Journal of Caring Sciences 2018;11(2):1231-1238.8. Crawford A, Benard V, King J, Thomas CC. Peer Reviewed: Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014. Preventing Chronic Disease 2016:13: E154. doi: 10.5888/pcd13.1602259. Modibbo FI, Dareng E, Bamisaye P, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ open 2016;6(1): e008533. http://dx.doi.org/10.1136/bmjopen-2015-00853310.
  5. Racey CS, Gesink DC. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self‐Collected HPV Testing. The Journal of Rural Health 2016;32(2):136-145. ttps://doi.org/10.1111/jrh.1213611. Akinlotan M, Bolin JN, Helduser J, Ojinnaka C, Lichorad A, McClellan D. Cervical cancer screening barriers and risk factor knowledge among uninsured women. Journal of community health 2017;42(4):770-778. DOI 10.1007/s10900-017-0316-912. Soper DS. A-priori Sample Size Calculator for Multiple Regression, 2019. [Software]. Available from http://www.danielsope